Jane Street Group, LLC Ovid Therapeutics Inc. Transaction History

Jane Street Group, LLC

  • $88.2 Billion
  • Q2 2024

A detailed history of Jane Street Group, LLC transactions in Ovid Therapeutics Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 98,590 shares of OVID stock, worth $110,420. This represents 0.0% of its overall portfolio holdings.

Number of Shares
98,590
Previous 53,580 84.01%
Holding current value
$110,420
Previous $163,000 53.99%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$0.7 - $3.34 $31,506 - $150,333
45,010 Added 84.01%
98,590 $75,000
Q1 2024

May 15, 2024
BUY
$2.72 - $4.04 $7,286 - $10,823
2,679 Added 5.26%
53,580 $163,000
Q4 2023

Feb 14, 2024
BUY
$2.98 - $3.78 $151,684 - $192,405
50,901 New
50,901 $163,000
Q1 2023

May 15, 2023
BUY
$1.88 - $2.85 $93,054 - $141,066
49,497 Added 83.73%
108,615 $280,000
Q4 2022

Feb 14, 2023
BUY
$1.43 - $1.89 $64,392 - $85,106
45,030 Added 319.63%
59,118 $109,000
Q3 2022

Nov 14, 2022
BUY
$1.84 - $2.26 $4,920 - $6,043
2,674 Added 23.43%
14,088 $26,000
Q3 2022

Nov 14, 2022
BUY
$1.84 - $2.26 $4,920 - $6,043
2,674 Added 23.43%
14,088 $26,000
Q2 2022

Aug 16, 2022
SELL
$1.69 - $3.31 $88,038 - $172,431
-52,094 Reduced 82.03%
11,414 $25,000
Q1 2022

May 17, 2022
BUY
$2.65 - $3.49 $168,296 - $221,642
63,508 New
63,508 $199,000
Q3 2021

Nov 16, 2021
SELL
$3.31 - $4.04 $254,780 - $310,970
-76,973 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$3.3 - $4.49 $121,644 - $165,510
36,862 Added 91.9%
76,973 $301,000
Q1 2021

May 18, 2021
BUY
$2.42 - $4.47 $97,068 - $179,296
40,111 New
40,111 $161,000
Q4 2020

Feb 17, 2021
SELL
$2.28 - $6.84 $79,998 - $239,995
-35,087 Closed
0 $0
Q3 2020

Nov 17, 2020
BUY
$5.39 - $8.24 $30,356 - $46,407
5,632 Added 19.12%
35,087 $201,000
Q2 2020

Aug 17, 2020
SELL
$2.67 - $7.91 $64,096 - $189,887
-24,006 Reduced 44.9%
29,455 $217,000
Q1 2020

May 15, 2020
BUY
$2.03 - $4.35 $108,525 - $232,555
53,461 New
53,461 $160,000
Q3 2019

Nov 14, 2019
SELL
$1.76 - $3.51 $92,063 - $183,604
-52,309 Closed
0 $0
Q2 2019

Aug 15, 2019
BUY
$1.59 - $2.14 $55,411 - $74,579
34,850 Added 199.61%
52,309 $97,000
Q1 2019

May 16, 2019
BUY
$1.77 - $3.56 $30,902 - $62,154
17,459 New
17,459 $31,000

Others Institutions Holding OVID

# of Institutions
75
Shares Held
39.2M
Call Options Held
10.3K
Put Options Held
200
View Full List

About Ovid Therapeutics Inc.

OVID Quotes by TradingView
  • Ticker OVID
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,419,400
  • Market Cap $78.9M
  • Description
  • Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...
More about OVID
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email